NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Onyx Bio

Onyx Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.onyx.bio/

Last Round

Seed Round

Feb 26, 2026

Total Funding Raised

$10M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Onyx Bio is a biotechnology company that builds a virtual immune system to accelerate and de-risk the development of precision medicines by integrating multiomics data with longitudinal patient records.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

multi-omicsprecision medicinedrug discoveryvirtual immune systembiotech data platformin silico biologybiomarker discoverypatient stratificationdecentralized clinical trialsDCTautoimmune researchbiological modelingdata as a serviceDaaSAI drug discoverydigital twin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onyx Bio Comparables

Compare Onyx Bio with similar companies based on industry and business-model similarity.

Onyx Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Onyx Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundFeb 26, 2026
SeedMar 12, 2025

Key People

Founding team and executive leadership

Amit Lakhani

Co-Founder CTO

Founding Team

Roger Chen

Cofounder CEO

Founding Team

Onyx Bio Investors

Notable investors and investment history

Onyx Bio investors
InvestorRounds
Pioneer FundSeed
Khosla VenturesSeed
First Round CapitalSeed
Y CombinatorSeed
TwentyTwo VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 64% MoM to 31.1K.

Onyx Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onyx Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onyx Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range8
Year Founded2024
Last FundingFeb 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.